Piperacillin And Tazobactam Injection, Powder, Lyophilized, For Solution
NDC Package 55150-121-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Piperacillin And Tazobactam (piperacillin sodium and tazobactam sodium) injection is piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Eugia Us Llc, this product is identified by NDC 55150-121 and is authorized under FDA application ANDA065498.

Identification & Billing

NDC Package Code
55150-121-50
Package Description
10 VIAL in 1 BOX / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product Code
55150-121
11-Digit Billing Format
55150012150
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA
RxNorm Crosswalk
  • RxCUI: 1659131 - piperacillin / tazobactam 2.25 GM Injection
  • RxCUI: 1659131 - piperacillin 2000 MG / tazobactam 250 MG Injection
  • RxCUI: 1659131 - piperacillin (as piperacillin sodium) 2000 MG / tazobactam (as tazobactam sodium) 250 MG Injection
  • RxCUI: 1659137 - piperacillin / tazobactam 3.375 GM Injection
  • RxCUI: 1659137 - piperacillin 3000 MG / tazobactam 375 MG Injection

Clinical Specifications

Proprietary Name
Piperacillin And Tazobactam
Non-Proprietary Name
Piperacillin Sodium And Tazobactam Sodium
Substance Name
Piperacillin Sodium; Tazobactam Sodium
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Piperacillin and tazobactam for injection is a combination product consisting of a penicillin-class antibacterial, piperacillin, and a β-lactamase inhibitor, tazobactam, indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the conditions listed below.

Regulatory & Marketing

Labeler Name
Eugia Us Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA065498
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-23-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55150-121). Click a package code to view its specific billing and regulatory data.

55150-121-09
10 VIAL in 1 BOX / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55150-121-50 identifies a specific commercial package of 10 vial in 1 box / 1 injection, powder, lyophilized, for solution in 1 vial of Piperacillin And Tazobactam, a human prescription drug labeled by Eugia Us Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains piperacillin sodium; tazobactam sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eugia Us Llc on January 23, 2012. The current certification is valid through December 31, 2026.

How is this Eugia Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55150012150. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55150-121-50
11-Digit CMS (5-4-2)
55150-0121-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.